Clinical Trial Update: Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

View source ↗

Summary

This completed clinical trial evaluated whether daily SMS reminders improve adherence to oral antipsychotics in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED